On the risk of secondary cancer from thymoma radiotherapy

医学 放射治疗 核医学 胸腺瘤 放射治疗计划 热释光剂量计 癌症 剂量计 放射科 外科 剂量学 内科学
作者
Wassim Jalbout,Rania Jbara,Chadia Rizk,Bassem Youssef
出处
期刊:Physics in Medicine and Biology [IOP Publishing]
卷期号:67 (15): 155015-155015 被引量:2
标识
DOI:10.1088/1361-6560/ac7c50
摘要

Abstract Objective. This study aims at quantifying the lifetime attributable risk of secondary fatal cancer (LARFAC) to patients receiving adjuvant radiotherapy treatment for thymoma, a neoplasm where cure rates and life expectancy are relatively high, patient age at presentation relatively low and indications for radiotherapy controversial depending on the disease stage. Approach. An anthropomorphic phantom was scanned, organs were contoured and a standard 6 MV 3DCRT treatment plan was produced for thymoma treatment. The phantom was loaded with thermoluminescent dosimeters (TLDs) and treated by linear accelerator per plan. The TLDs were subsequently read for out-of-field dose distribution while in-field dose distribution was obtained from the planning system. Sex and age-specific lifetime radiogenic cancer risk was calculated as the sum of in-field risk and out-of-field risk. The latter risk was estimated using hybrid ICRP 2007 103-BEIR VII tables of organ-specific risks based on the linear-no threshold (LNT) model and applicable at low doses, while the former using mathematical risk models applicable at high doses. Main results. The LARFAC associated with a prescribed dose of 50 Gy to target volume in 25 fractions was in the approximate range of 1%–3%. The risk was higher for young and female patients. The largest contributing organ to this risk were the lungs by far. Using the LNT model inappropriately to calculate risk at therapeutic doses (in-field) would overestimate the risk up to tenfold. Significance. The LARFAC to patient from thymoma radiotherapy was quantified taking into consideration the inapplicability of the LNT model at therapeutic doses. The risk is not negligible; the information may be relevant to patients and clinicians.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
冷傲迎梦完成签到,获得积分20
2秒前
2秒前
vinni发布了新的文献求助10
2秒前
仙人殊恍惚应助研友_ZGR70n采纳,获得10
2秒前
李明月完成签到,获得积分10
2秒前
zhongxuejie完成签到,获得积分10
2秒前
yanziwu94完成签到,获得积分10
2秒前
xh发布了新的文献求助10
2秒前
2秒前
王加通完成签到,获得积分10
2秒前
3秒前
精明的甜瓜应助神羊采纳,获得20
3秒前
asd发布了新的文献求助10
3秒前
ghy完成签到 ,获得积分10
4秒前
火星上芹菜完成签到,获得积分10
5秒前
Yiya发布了新的文献求助10
6秒前
毛通完成签到,获得积分10
6秒前
Zhanghh87应助翎尧采纳,获得10
6秒前
启程完成签到,获得积分10
7秒前
yyj完成签到,获得积分10
7秒前
kydd完成签到,获得积分10
7秒前
lun完成签到,获得积分10
7秒前
7秒前
齐天大圣应助风清扬采纳,获得50
7秒前
完美世界应助r93527005采纳,获得10
8秒前
乐乐应助xh采纳,获得10
8秒前
tyh完成签到,获得积分10
9秒前
梁晓玲发布了新的文献求助10
9秒前
10秒前
春鸮鸟完成签到 ,获得积分10
10秒前
月下荷花完成签到,获得积分10
10秒前
喵小薇完成签到 ,获得积分10
11秒前
潇湘夜雨完成签到,获得积分10
11秒前
小不遛w完成签到,获得积分10
11秒前
11秒前
人不犯二枉少年完成签到,获得积分10
11秒前
谭刚发布了新的文献求助10
12秒前
12秒前
刘大恒发布了新的文献求助10
12秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
A new approach to the extrapolation of accelerated life test data 1000
徐淮辽南地区新元古代叠层石及生物地层 500
Coking simulation aids on-stream time 450
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4016130
求助须知:如何正确求助?哪些是违规求助? 3556145
关于积分的说明 11320169
捐赠科研通 3289087
什么是DOI,文献DOI怎么找? 1812382
邀请新用户注册赠送积分活动 887923
科研通“疑难数据库(出版商)”最低求助积分说明 812051